Company News

Geron Corp. Grants License to P&G

Author Image

By: TOM BRANNA

Editor

Biopharmaceutical company Geron Corp. has granted a non-exclusive license to Procter & Gamble relating to Geron’s human telomerase reverse transcriptase (hTERT) technology for cell research applications. Financial terms of the agreement were not disclosed. P&G plans to use the technology to create immortalized cell lines from certain types of skin cells to study the regulation of cell function and to develop biological tests for screening purposes. Cell lines immortalized with hTERT ...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters